Zimmer Biomet Gross Profit vs. Current Valuation
| ZBH Stock | USD 110.22 1.82 1.68% |
Gross Profit | First Reported 2000-03-31 | Previous Quarter 1.2 B | Current Value 1.3 B | Quarterly Volatility 396.7 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.8 | 0.7182 |
|
| |||||
| Operating Profit Margin | 0.22 | 0.1728 |
|
|
For Zimmer Biomet profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Zimmer Biomet to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Zimmer Biomet Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Zimmer Biomet's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Zimmer Biomet Holdings over time as well as its relative position and ranking within its peers.
Zimmer |
Zimmer Biomet's Revenue Breakdown by Earning Segment
Check out Your Current Watchlist.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.597 | Dividend Share 0.96 | Earnings Share 5.24 | Revenue Per Share 37.006 | Quarterly Revenue Growth 0.04 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Zimmer Biomet Holdings Current Valuation vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Zimmer Biomet's current stock value. Our valuation model uses many indicators to compare Zimmer Biomet value to that of its competitors to determine the firm's financial worth. Zimmer Biomet Holdings is rated below average in gross profit category among its peers. It is rated below average in current valuation category among its peers reporting about 5.68 of Current Valuation per Gross Profit. As of now, Zimmer Biomet's Gross Profit is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zimmer Biomet's earnings, one of the primary drivers of an investment's value.Zimmer Biomet's Earnings Breakdown by Geography
Zimmer Current Valuation vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Zimmer Biomet |
| = | 4.92 B |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Zimmer Biomet |
| = | 27.95 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Zimmer Current Valuation vs Competition
Zimmer Biomet Holdings is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 762.44 Billion. Zimmer Biomet holds roughly 27.95 Billion in current valuation claiming about 4% of equities under Health Care industry.
Zimmer Biomet Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Zimmer Biomet, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Zimmer Biomet will eventually generate negative long term returns. The profitability progress is the general direction of Zimmer Biomet's change in net profit over the period of time. It can combine multiple indicators of Zimmer Biomet, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -191 M | -181.4 M | |
| Operating Income | 1.3 B | 853 M | |
| Income Before Tax | 1.1 B | 1.1 B | |
| Net Income | 1 B | 585 M | |
| Income Tax Expense | 42.2 M | 66.9 M | |
| Net Income Applicable To Common Shares | 266.1 M | 252.8 M | |
| Total Other Income Expense Net | -210.4 M | -220.9 M | |
| Net Income From Continuing Ops | 475.2 M | 445.5 M | |
| Non Operating Income Net Other | -115.2 M | -109.4 M | |
| Interest Income | 189.5 M | 148.5 M | |
| Net Interest Income | -193.5 M | -203.2 M | |
| Change To Netincome | 435.3 M | 457 M | |
| Net Income Per Share | 4.91 | 5.15 | |
| Income Quality | 1.54 | 1.38 | |
| Net Income Per E B T | 0.96 | 0.81 |
Zimmer Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Zimmer Biomet. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Zimmer Biomet position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Zimmer Biomet's important profitability drivers and their relationship over time.
Use Zimmer Biomet in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Zimmer Biomet position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zimmer Biomet will appreciate offsetting losses from the drop in the long position's value.Zimmer Biomet Pair Trading
Zimmer Biomet Holdings Pair Trading Analysis
The ability to find closely correlated positions to Zimmer Biomet could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Zimmer Biomet when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Zimmer Biomet - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Zimmer Biomet Holdings to buy it.
The correlation of Zimmer Biomet is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Zimmer Biomet moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Zimmer Biomet Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Zimmer Biomet can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Zimmer Biomet position
In addition to having Zimmer Biomet in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Farming Thematic Idea Now
Farming
Companies producing farming products and providing services for farmers. The Farming theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Farming Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Current Watchlist. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
To fully project Zimmer Biomet's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Zimmer Biomet Holdings at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Zimmer Biomet's income statement, its balance sheet, and the statement of cash flows.